Regenxbio Inc.
Records under this name other than the patents Regenxbio Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 12 patents it holds.
Showing 1 to 6 of 6 · Back to Regenxbio Inc.
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 9,827,295 | Methods to Treat Mucopolysaccharide Type I or Deficiency in Alpha-L-Iduronidase Using a Recombinant Adeno-Associated Virus Encoding Alpha-L-Iduronidase Formerly held In force · High confidence | In force | High confidence | |
| US 12,121,567 | Methods to Treat Mucopolysaccharidosis Type II or Deficiency in IDURONATE-2-Sulfatase Using a Recombinant Adeno-Associated Virus (AAV) Vector Encoding IDURONATE-2-Sulfatase Formerly held In force · Medium confidence | In force | Medium confidence | |
| US 12,070,510 | Injection of Single-Stranded or Self-Complementary Adeno-Associated Virus 9 into the Cerebrospinal Fluid Formerly held In force · High confidence | In force | High confidence | |
| US 11,613,739 | Treatment of Mucopolysaccharidosis II with Recombinant Human IDURONATE-2-Sulfatase (IDS) Produced by Human Neural or Glial Cells Formerly held In force · High confidence | In force | High confidence | |
| US 11,986,515 | Treatment of Mucopolysaccharidosis II with Recombinant Human IDURONATE-2-Sulfatase (IDS) Formerly held In force · Medium confidence | In force | Medium confidence | |
| US 12,247,213 | Treatment of mucopolysaccharidosis IVA Formerly held In force · From the USPTO record | In force | From the USPTO record |